Infectious Diseases News and Research

RSS

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025.

From Bruker Cellular Analysis 25 Apr 2025

Measles could become endemic again in the United States

Childhood vaccination rates have been falling in the United States, especially since the start of the COVID-19 pandemic.

24 Apr 2025

Global immunization progress threatened by misinformation and funding cuts

Immunization efforts are under growing threat as misinformation, population growth, humanitarian crises and funding cuts jeopardize progress and leave millions of children, adolescents and adults at risk, warn WHO, UNICEF, and Gavi during World Immunization Week, 24–30 April.

24 Apr 2025

Baloxavir marboxil shows promise in reducing household flu spread

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to research in the New England Journal of Medicine.

24 Apr 2025

AI-powered BEACON platform enhances global disease surveillance

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate information on emerging infectious diseases affecting humans, animals, and the environment.

24 Apr 2025

New strategy for TB screening aims to save lives

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not always accurately detect disease.

24 Apr 2025

Scientists uncover why Lyme disease symptoms may linger after treatment

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post Treatment Lyme Disease (PTLD).

23 Apr 2025

Scientists develop promising new drug candidates against coronaviruses

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could cause future pandemics.

23 Apr 2025

San Antonio scientists use machine learning to identify potential treatments for deadly viruses

A team of San Antonio-based biomedical researchers trained a machine learning algorithm to identify more than two dozen viable treatments for diseases caused by zoonotic pathogens that can jump from animal hosts to infect humans.

23 Apr 2025

Scientists uncover surprising new link between gut health and blood cancer risk

Scientists at Cincinnati Children's along with an international team of researchers have discovered a surprising new connection between gut health and blood cancer risk-one that could transform how we think about aging, inflammation, and the early stages of leukemia.

23 Apr 2025

Light-induced DNA detection technique enables rapid, ultra-sensitive genetic analysis

PCR genetic analysis has been in the spotlight since COVID-19, but light is now further facilitating PCR-free methods.

22 Apr 2025

High-risk adults often do not receive timely flu treatment, study finds

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment.

22 Apr 2025

Fruit fly study reveals key brain proteins that help prevent seizures

One in ten people will have at least one seizure in their life, but effective treatments for seizures remain very limited, in part due to incomplete understanding of the brain mechanisms involved.

21 Apr 2025

Experimental cancer drug shows promise in boosting tuberculosis treatment

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, based on mouse-model research of the lung-damaging disease.

21 Apr 2025

Study highlights the importance of clean water and sanitation in controlling endemic cholera

Public health strategies, from vaccination to improving sanitary conditions, may have different impacts depending on whether a disease is endemic - persisting in a particular location for an extended period of time - or a new outbreak, because the dominant transmission routes may differ, according to a new study.

18 Apr 2025

Lower temperatures increase the risk of gastroenteritis among Rohingya refugees in Bangladesh

Colder temperatures are linked with increased risk of diarrhea among Rohingya refugees in Bangladesh, emphasizing the need for climate-sensitive health strategies in refugee settings.

18 Apr 2025

Why measles is resurging in vulnerable countries despite global progress

Global measles incidence, mortality, and DALY rates in children under five dropped significantly from 1990 to 2021. However, the COVID-19 pandemic disrupted vaccination efforts, leading to coverage declines and elevated outbreak risks in low-SDI regions.

17 Apr 2025

Vaccine trial shows promise for saving California condors from bird flu

Researchers evaluated the safety and immune response of a poultry-derived H5N1 avian influenza vaccine in black vultures and critically endangered California condors. The findings support the use of vaccination as a conservation tool against deadly avian flu outbreaks.

17 Apr 2025

Climate change poses global risk to safe blood supply

A new study published in The Lancet Planetary Health suggests a changing climate threatens the continuous availability of safe blood across the world.

16 Apr 2025

Gut bacteria turn bile acids into allies against cancer

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators.

16 Apr 2025